0 0

Short Talk: Tumor CD155 Drives Resistance to Immunotherapy by Downregulating the Activating Receptor CD226 in CD8+ T Cells

Aug 17, 2020 4:55pm ‐ Aug 17, 2020 5:10pm

Credits: None available.

Speaker(s):

Matthias Braun, MD, QIMR Berghofer, Australia

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.